Skip to search formSkip to main contentSkip to account menu

Acromegaly

Known as: Acromegaly [Disease/Finding], Somatotropin Hypersecretion Syndromes (Acromegaly), Inappropriate GH Secretion Syndrome (Acromegaly) 
A condition caused by prolonged exposure to excessive HUMAN GROWTH HORMONE in adults. It is characterized by bony enlargement of the FACE; lower jaw… 
National Institutes of Health

Related topics

Related topics

35 relations
1 ML Octreotide 0.1 MG/ML Injection2-Bromoergocryptine MesylateAdenoma, AcidophilBone Diseases

Narrower (4)

Acromegaloid facial appearance syndromeAcromegaloid features, overgrowth, cleft palate, and herniaRosenthal-Kloepfer syndromeacromegalic joint disease

Broader (3)

Bone Diseases, DevelopmentalHyperpituitarismgigantism and acromegaly

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
1986
Highly Cited
1986
Plasma growth hormone responses to somatostatin (SRIH) and SRIH receptors in pituitary adenomas in acromegalic patients.
The plasma GH response to somatostatin (SRIH) infusion and SRIH receptors in pituitary adenoma cell membranes were investigated… 
1986
1986
Chronic treatment of pathological hyperprolactinemia and acromegaly with the new ergot derivative terguride.
The long term effectiveness and tolerance of terguride, a new ergot derivative, as initial therapy were evaluated in 20 patients… 
Highly Cited
1985
Highly Cited
1985
Antibody against acid-stable insulin-like growth factor binding protein detects 150,000 mol wt growth hormone-dependent complex in human plasma.
In order to measure the 150,000 mol wt binding complex for insulin-like growth factors in human plasma without the need for… 
1985
1985
Somatotropic adenoma manifested by galactorrhea without acromegaly.
In two of eight premenopausal women with somatotropic adenomas, galactorrhea was the earliest clinical feature, associated in one… 
1980
1980
Modulation of homologous receptor concentrations: a sensitive radioassay for human growth hormone in acromegalic, newborn, and stimulated plasma.
Exposure of cultured lymphocytes (IM-9) to human GH (hGH) leads to a time- and concentration-dependent reduction in binding by… 
1979
1979
The dynamics of growth hormone and prolactin secretion in acromegalic patients with "mixed" pituitary tumours.
1977
1977
Effect of bromoergocriptine on TRH-induced growth hormone and prolactin release in acromegalic patients.
In an attempt to evaluate the dynamics of growth hormone (GH) and prolactin secretion in acromegalic patients, the response of… 
1976
1976
CONVENTIONAL PITUITARY IRRADIATION IN ACROMEGALY
Thirty-one patients who had been treated for acromegaly for 1-21 years with conventional pituitary irradiation were re-examined… 
Highly Cited
1971
Highly Cited
1971
Human prolactin: measurement in plasma by in vitro bioassay.
Prolactin has been measured in unextracted human plasma by a sensitive and specific in vitro bioassay. Secretory activity of… 
1965
1965
Heavy-particle therapy in acromegaly and Cushing disease.
A total of 349 patients with pituitary tumors, including acromegaly, Cushing disease, Nelson syndrome, prolactin-secreting…